Additionally, GLP-1RAs protect against CVD by improving endothelial dysfunction, an early phase of atherosclerosis [28,29], triggered by high blood pressure, diabetes, and elevated cholesterol [30,31]
doi: 10.1016/j.rbmo.2021.06.030 83 ZhaoYGongPChenYNwachukwuJCSrinivasanSKoCet al
next to Wild Strawberry Cafe
To view or add a comment, sign in Genentech Reports the US FDA's Approval of Gazyva (Obinutuzumab) to Treat Lupus Nephritis #genentech #gazyva #obinutuzumab #lupusnephritis #usfda #regulatory #monoclonalantibody #nobility #regency #pii #piii #ro5072759 #rg7159 #r7159 #ga101 To view or add a comment, sign in Potential future royalty income from Metsera/Pfizer* obesity drug candidates As highlighted in our 2025 half-yearly results, IP Group has financial exposure to several of Metseras obesity drug programmes, following its acquisition of our former portfolio company Zihipp Limited in 2023
These proteins regulate apoptosis, programmed cell death
Contact us now to book your consultation